Additional Phase 3 readouts in diabetes, cardiovascular disease, and several other indications are scheduled through 2026
In non-alcoholic steatohepatitis (NASH)the inflammatory form of NAFLDthis anti-inflammatory potential may be particularly relevant, though clinical evidence remains limited
The best time to take your GLP-1 injection is whichever time you can maintain consistently week after week
In 2017, the US Food and Drug Administration (FDA) authorized semaglutide as the seventh clinically available GLP-1RA
24/7 portal & support Manage refills, request dose changes, and message your care team anytime from your secure patient portal
For researchers studying wound biology, the combined peptide system provides a model for exploring how vascular signaling pathways and cytoskeletal-regulated cell movement interact during tissue remodeling processes